13F-HR 1 w00144e13fvhr.txt FORM 13F UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 13F Form 13F COVER PAGE Report for Calendar Year or Quarter Ended: June 30, 2004 Check here if Amendment [ ]; Amendment Number: This Amendment (Check only one.): [ ] is a restatement. [ ] adds new holdings entries. Institutional Investment Manager Filing this Report: Name: BB Biotech AG Address: Vordergasse 3 Schaffhausen Switzerland CH-8200 Form 13F File Number: 28-6964 The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables are considered integral parts of this form. Person Signing this Report on Behalf of Reporting Manager: Name: Adrian Bruengger Title: SIGNING AUTHORITY ---------------- Phone: 41 (01) 267 67 00 Signature, Place, and Date of Signing: /s/Adrian Bruengger ------------------------------------- Schaffhausen, Switzerland, August 10, 2004
Report Type (Check only one.): [ ] 13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager are reported in this report.) [ ] 13F NOTICE. (Check here if no holdings reported are in this report, and all holdings are reported by other reporting manager(s).) [X] 13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager are reported in this report and a portion are reported by other reporting manager(s).) List of Other Managers Reporting for this Manager: Name Biotech Focus N.V. Biotech Invest N.V. Biotech Target N.V. Biotech Growth N.V. Form 13F SUMMARY PAGE Report Summary: Number of Other Included Managers: 4 Form 13F Information Table Entry Total: 17 Form 13F Information Table Value Total: $1,402,363 (thousands) List of Other Included Managers: Provide a numbered list of the name(s) and Form 13F file number(s) of all institutional investment managers with respect to which this report is filed, other than the manager filing this report. No. Name 1 Biotech Focus N.V. 2 Biotech Invest N.V. 3 Biotech Target N.V. 4 Biotech Growth N.V. BB BIOTECH AG FORM 13F INFORMATION TABLE
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8 -------- -------- -------- -------- -------- ---------- -------- -------- TITLE VALUE SHS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY NAME OF ISSUER OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGERS SOLE SHARED NONE -------------- -------- ----- -------- ------- --- ---- ---------- -------- ------ ------ ---- Amgen Inc. COM 031162100 54,570 1,000,000 SH DEFINED 1 1,000,000 NONE NONE AtheroGenics, Inc. COM 047439104 39,012 2,050,000 SH DEFINED 3 2,050,000 NONE NONE Biogen Idec Inc. COM 09062X103 164,450 2,600,000 SH DEFINED 1 2,600,000 NONE NONE Celgene Corporation COM 151020104 165,516 2,890,600 SH DEFINED 2 2,890,600 NONE NONE Cell Therapeutics, Inc. COM 150934107 22,110 3,000,000 SH DEFINED 3 3,000,000 NONE NONE DURECT Corporation COM 266605104 7,802 2,254,957 SH DEFINED 3 2,254,957 NONE NONE Elan Corporation, plc COM 284131208 5,096 206,000 SH DEFINED 2 206,000 NONE NONE EyeTech COM 302297106 149,205 3,476,362 SH DEFINED 4 3,476,362 NONE NONE Pharmaceuticals, Inc. Genzyme Corporation COM 372917104 105,499 2,229,000 SH DEFINED 1 2,229,000 NONE NONE Gilead Sciences, Inc. COM 375558103 201,000 3,000,000 SH DEFINED 1 3,000,000 NONE NONE ICOS Corporation COM 449295104 59,680 2,000,000 SH DEFINED 3 2,000,000 NONE NONE Ligand Pharmaceuticals COM 53220K207 111,232 6,400,000 SH DEFINED 2 6,400,000 NONE NONE Incorporated Pozen Inc. COM 73941U102 15,186 2,217,000 SH DEFINED 3 2,217,000 NONE NONE Sepracor Inc. COM 817315104 158,700 3,000,000 SH DEFINED 1 3,000,000 NONE NONE Telik, Inc. COM 87959M109 4,975 208,400 SH DEFINED 3 208,400 NONE NONE The Medicines Company COM 584688105 124,300 4,074,075 SH DEFINED 3 4,074,075 NONE NONE Virologic, Inc. COM 92823R201 14,030 5,726,430 SH DEFINED 3,4 5,726,430 NONE NONE